Latest Breaking News On - Arthura levin - Page 1 : comparemela.com

Arthur A Levin Sells 40,000 Shares of Avidity Biosciences, Inc (NASDAQ:RNA) Stock

Avidity Biosciences, Inc. (NASDAQ:RNA – Get Free Report) Director Arthur A. Levin sold 40,000 shares of Avidity Biosciences stock in a transaction that occurred on Wednesday, June 12th. The shares were sold at an average price of $35.07, for a total transaction of $1,402,800.00. Following the completion of the transaction, the director now directly owns […]

Los angelesUnited statesArthura levinLos angeles capital managementProshare advisorsCantor fitzgeraldAvidity biosciences company profileAvidity biosciences incAlps advisors incBoard of administration florida retirement systemNeedham companyHennion walsh asset management incSecurities exchange commissionAvidity biosciencesGet free reportDirector arthur

Avidity Biosciences (NASDAQ:RNA) Trading Down 4 3%

Shares of Avidity Biosciences, Inc. (NASDAQ:RNA – Get Free Report) traded down 4.3% on Tuesday . The stock traded as low as $26.07 and last traded at $26.27. 447,285 shares were traded during mid-day trading, a decline of 60% from the average session volume of 1,124,135 shares. The stock had previously closed at $27.45. Analyst […]

United statesArthura levinQuadrant capital groupPrivium fund managementNisa investment advisorsAvidity biosciences company profileJanney montgomery scottAvidity biosciences incCantor fitzgeraldNeedham companyChina universal asset management coAvidity biosciencesGet free reportDirector arthurInvestment advisorsCapital group

Avidity Biosciences, Inc (NASDAQ:RNA) Receives $41 33 Consensus PT from Brokerages

Shares of Avidity Biosciences, Inc. (NASDAQ:RNA – Get Free Report) have been assigned an average recommendation of “Buy” from the six analysts that are currently covering the firm, Marketbeat reports. Six analysts have rated the stock with a buy rating. The average 1-year price objective among brokers that have covered the stock in the last […]

United statesSarah boyceArthura levinQuadrant capital groupDaiwa securities group incNeedham companyNisa investment advisorsCantor fitzgeraldChina universal asset management coSecurities exchange commissionAvidity biosciences incAvidity biosciencesGet free reportBiosciences stock downDirector arthurExchange commission

Avidity Biosciences, Inc (NASDAQ:RNA) Given Consensus Rating of Buy by Brokerages

Avidity Biosciences, Inc. (NASDAQ:RNA – Get Free Report) has earned a consensus rating of “Buy” from the six ratings firms that are covering the company, MarketBeat.com reports. Six research analysts have rated the stock with a buy rating. The average 1-year price objective among brokers that have covered the stock in the last year is […]

United statesArthura levinSarah boyceAvidity biosciences incVanguard group incNeedham companyCantor fitzgeraldAvoro capital advisorsPricet rowe associates incAvidity biosciencesGet free reportBiosciences trading downDirector arthurCapital advisorsGet freeAvidity biosciences daily

Insider Selling: Avidity Biosciences, Inc (NASDAQ:RNA) Director Sells $149,500 00 in Stock

Insider Selling: Avidity Biosciences, Inc (NASDAQ:RNA) Director Sells $149,500 00 in Stock
tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.

United statesArthura levinCantor fitzgeraldAvidity biosciences incNeedham companyPricet rowe associates incVanguard group incAvoro capital advisorsAvidity biosciencesGet free reportDirector arthurCapital advisorsChardan capitalAvidity biosciences daily